MERCURIUS CYANATUS pellet

Land: Vereinigte Staaten

Sprache: Englisch

Quelle: NLM (National Library of Medicine)

Wirkstoff:

MERCURIC CYANIDE (UNII: RWG7BD1032) (MERCURIC CYANIDE - UNII:RWG7BD1032)

Verfügbar ab:

Hahnemann Laboratories, Inc.

Verabreichungsweg:

ORAL

Verschreibungstyp:

OTC DRUG

Berechtigungsstatus:

unapproved homeopathic

Fachinformation

MERCURIUS CYANATUS- MERCURIUS CYANATUS PELLET
HAHNEMANN LABORATORIES, INC.
_Disclaimer: This homeopathic product has not been evaluated by the
Food and Drug Administration for_
_safety or efficacy. FDA is not aware of scientific evidence to
support homeopathy as effective._
----------
SINGLE LABEL IMAGE CONTAINS CONTENT FOR SECTIONS 1-17.
MERCURIUS CYANATUS
mercurius cyanatus pellet
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN OTC DRUG
ITE M CODE (SOURCE )
NDC:6 3545-6 8 3
ROUTE OF ADMINISTRATION
ORAL, BUCCAL, SUBLINGUAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
MERCURIC CYANIDE (UNII: RWG7BD10 32) (MERCURIC CYANIDE -
UNII:RWG7BD10 32)
MERCURIC
CYANIDE
30 [hp_C]
in 1 [hp_C]
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
SUCRO SE (UNII: C151H8 M554)
PRODUCT CHARACTERISTICS
COLOR
white
S CORE
no sco re
S HAP E
ROUND
S IZ E
3mm
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:6 3545-6 8 3-
0 1
240 [hp_C] in 1 VIAL, GLASS; Type 0 : No t a Co mbinatio n
Pro duc t
0 5/0 4/20 17
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
Hahnemann Laboratories, Inc.
unappro ved ho meo pathic
0 5/0 4/20 17
LABELER -
Hahnemann Laboratories, Inc. (147098081)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Hahnemann Labo rato ries, Inc.
1470 9 8 0 8 1
ma nufa c ture (6 3545-6 8 3)
Revised: 5/2017